The DOI matches its Crossref record; 865 of the 865 references it cites were found in a registry or an index.
Strategies to Address Low Drug Solubility in Discovery and Development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Principles of polymer chemistry
(1995) · Choice Reviews Online · doi:10.5860/choice.33-2140 · Cited by 15,218
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
The Cambridge Structural Database: a quarter of a million crystal structures and rising
Allen, F. H. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003890 · Cited by 9,898
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Formation of Glasses from Liquids and Biopolymers
Angell, C. A. (1995) · Science · doi:10.1126/science.267.5206.1924 · Cited by 4,799
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Interfaces and the driving force of hydrophobic assembly
Chandler, D. (2005) · Nature · doi:10.1038/nature04162 · Cited by 3,591
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Handbook of Pharmaceutical Excipients
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (1994) · Cited by 3,493
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Zur Lehre von der Wirkung der Salze: Zweite Mittheilung
Hofmeister, F. (1888) · Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01918191 · Cited by 2,956
Frank, H. S., & Evans, M. W. (1945) · The Journal of Chemical Physics · doi:10.1063/1.1723985 · Cited by 2,880
The Nature of the Glassy State and the Behavior of Liquids at Low Temperatures.
Kauzmann, W. (1948) · Chemical Reviews · doi:10.1021/cr60135a002 · Cited by 2,834
Gordon, M., & Taylor, J. S. (1952) · Journal of Applied Chemistry · doi:10.1002/jctb.5010020901 · Cited by 2,621
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,574
Under what conditions can a glass be formed?
Turnbull, D. (1969) · Contemporary Physics · doi:10.1080/00107516908204405 · Cited by 2,229
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Rate of Nucleation in Condensed Systems
Turnbull, D., & Fisher, J. C. (1949) · The Journal of Chemical Physics · doi:10.1063/1.1747055 · Cited by 2,159
Cyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
Theoretical perspective on the glass transition and amorphous materials
Berthier, L., & Biroli, G. (2011) · Reviews of Modern Physics · doi:10.1103/revmodphys.83.587 · Cited by 2,133
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
Hancock, B. C., & Zografi, G. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601896 · Cited by 1,922
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Self-citationPharmaceutical Applications of Solid Dispersion Systems
Chiou, W. L., & Riegelman, S. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600902 · Cited by 1,799
Viscous Liquids and the Glass Transition. II. Secondary Relaxations in Glasses of Rigid Molecules
Johari, G. P., & Goldstein, M. (1970) · The Journal of Chemical Physics · doi:10.1063/1.1674335 · Cited by 1,786
A method for estimating both the solubility parameters and molar volumes of liquids
Fedors, R. F. (1974) · Polymer Engineering & Science · doi:10.1002/pen.760140211 · Cited by 1,779
Cyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Pharmaceutical Particle Engineering via Spray Drying
Vehring, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,691
Stable Prenucleation Calcium Carbonate Clusters
Gebauer, D., Völkel, A., & Cölfen, H. (2008) · Science · doi:10.1126/science.1164271 · Cited by 1,673
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,648
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
Vasconcelos, T., Sarmento, B., & Costa, P. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.09.005 · Cited by 1,566
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Wanka, G., Hoffmann, H., & Ulbricht, W. (1994) · Macromolecules · doi:10.1021/ma00093a016 · Cited by 1,496
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Salt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,425
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,405
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Self-citationCD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Self-citationNanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Febbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Particle design using supercritical fluids: Literature and patent survey
Jung, J., & Perrut, M. (2001) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(01)00064-x · Cited by 1,141
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., & Morris, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011052932607 · Cited by 1,071
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Studies of Intestinal Digestion and Absorption in the Human1
Borgström, B., Dahlqvist, A., Lundh, G., & Sjövall, J. (1957) · Journal of Clinical Investigation · doi:10.1172/jci103549 · Cited by 1,048
Pharmaceutical applications of cyclodextrins: basic science and product development
Loftsson, T., & Brewster, M. E. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01030.x · Cited by 1,031
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Vishweshwar, P., McMahon, J. A., Bis, J. A., & Zaworotko, M. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20578 · Cited by 968
The mechanisms of drug release from solid dispersions in water-soluble polymers
Craig, D. Q. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00891-2 · Cited by 963
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Controlling the Fiber Diameter during Electrospinning
Fridrikh, S. V., Yu, J. H., Brenner, M. P., & Rutledge, G. C. (2003) · Physical Review Letters · doi:10.1103/physrevlett.90.144502 · Cited by 941
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Taylor, L. S., & Zografi, G. (1997) · Pharmaceutical Research · doi:10.1023/a:1012167410376 · Cited by 903
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 898
Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures
Hancock, B. C., Shamblin, S. L., & Zografi, G. (1995) · Pharmaceutical Research · doi:10.1023/a:1016292416526 · Cited by 889
Pharmaceutical Applications of Polymorphism
Haleblian, J., & McCrone, W. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580802 · Cited by 855
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
Solubility Advantage of Pharmaceutical Cocrystals
Good, D. J., & Rodríguez-Hornedo, N. (2009) · Crystal Growth & Design · doi:10.1021/cg801039j · Cited by 841
On a General Relation Involving the Glass Temperature and Coefficients of Expansion of Polymers
Simha, R., & Boyer, R. F. (1962) · The Journal of Chemical Physics · doi:10.1063/1.1733201 · Cited by 827
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Pharmaceutical Applications of Hot-Melt Extrusion: Part I
Crowley, M. M., Zhang, F., Repka, M. A., Thumma, S., Upadhye, S. B., Kumar Battu, S., McGinity, J. W., & Martin, C. (2007) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701498759 · Cited by 824
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
The Role of ABC Transporters in Clinical Practice
Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 817
Iqbal, J., & Hussain, M. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90899.2008 · Cited by 811
Building co-crystals with molecular sense and supramolecular sensibility
Aakeröy, C. B., & Salmon, D. J. (2005) · CrystEngComm · doi:10.1039/b505883j · Cited by 770
Tønnesen, H. H., Másson, M., & Loftsson, T. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00323-x · Cited by 767
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
Melt extrusion: from process to drug delivery technology
Breitenbach, J. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00061-9 · Cited by 742
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Vekilov, P. G. (2010) · Crystal Growth & Design · doi:10.1021/cg1011633 · Cited by 736
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Structural Relaxation of Polymer Glasses at Surfaces, Interfaces, and In Between
Priestley, R. D., Ellison, C. J., Broadbelt, L. J., & Torkelson, J. M. (2005) · Science · doi:10.1126/science.1112217 · Cited by 729
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Stella, V. J., & He, Q. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310945 · Cited by 700
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Baird, J. A., Van Eerdenbrugh, B., & Taylor, L. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22197 · Cited by 697
Review: Nucleation in solutions revisited
Kashchiev, D., & van Rosmalen, G. M. (2003) · Crystal Research and Technology · doi:10.1002/crat.200310070 · Cited by 695
Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
McNamara, D. P., Childs, S. L., Giordano, J., Iarriccio, A., Cassidy, J., Shet, M. S., Mannion, R., O'Donnell, E., & Park, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9032-3 · Cited by 690
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Chemburkar, S. R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., et al. (2000) · Organic Process Research & Development · doi:10.1021/op000023y · Cited by 687
Prenucleation clusters and non-classical nucleation
Gebauer, D., & Cölfen, H. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.005 · Cited by 682
Solubility parameters as predictors of miscibility in solid dispersions
Greenhalgh, D. J., Williams, A. C., Timmins, P., & York, P. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9900856 · Cited by 674
Vippagunta, S. R., Brittain, H. G., & Grant, D. J. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00097-7 · Cited by 670
Solubility and Solubilization in Aqueous Media
Yalkowsky, S. H. (1999) · Cited by 669
Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures
Jouyban, A. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3pp4k · Cited by 669
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., & Lou, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.002 · Cited by 666
Pharmaceutical cocrystals: An overview
Qiao, N., Li, M., Schlindwein, W., Malek, N., Davies, A., & Trappitt, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.037 · Cited by 665
Applied Surfactants: Principles and Applications
Tadros, T. F. (2005) · Medical Entomology and Zoology · Cited by 649
The digestion of dietary triacylglycerols
Mu, H. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00050-x · Cited by 635
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Cubic phase gels as drug delivery systems
Shah, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00108-9 · Cited by 625
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Self-citationIshikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Friesen, D. T., Shanker, R., Crew, M., Smithey, D. T., Curatolo, W. J., & Nightingale, J. A. S. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000793 · Cited by 610
Self-citationMerisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Desiraju, G. R. (2001) · Nature · doi:10.1038/35086640 · Cited by 602
Lunkenheimer, P., Schneider, U., Brand, R., & Loid, A. (2000) · Contemporary Physics · doi:10.1080/001075100181259 · Cited by 602
Surfactant Systems: Their chemistry, pharmacy and biology
Attwood, D., & Florence, A. J. (1983) · Medical Entomology and Zoology · Cited by 601
Drug polymorphism and dosage form design: a practical perspective
Singhal, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.008 · Cited by 596
Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility
Marsac, P. J., Shamblin, S. L., & Taylor, L. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9063-9 · Cited by 592
Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy
ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591
Nanoemulsion- and emulsion-based delivery systems for curcumin: Encapsulation and release properties
Ahmed, K., Li, Y., McClements, D. J., & Xiao, H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.11.039 · Cited by 586
Crystal structures of drugs: advances in determination, prediction and engineering
Datta, S., & Grant, D. J. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1280 · Cited by 583
Review: physical chemistry of solid dispersions
Janssens, S., & Van den Mooter, G. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.12.0001 · Cited by 580
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Chiappetta, D. A., & Sosnik, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.022 · Cited by 567
The utility of cyclodextrins for enhancing oral bioavailability
Carrier, R. L., Miller, L. A., & Ahmed, I. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.018 · Cited by 557
Prodrug strategies to overcome poor water solubility
Stella, V. J., & Nti-Addae, K. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.013 · Cited by 554
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs
Salonen, J., Laitinen, L., Kaukonen, A. M., Tuura, J., Björkqvist, M., Heikkilä, T., Vähä-Heikkilä, K., Hirvonen, J., & Lehto, V.-P. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.017 · Cited by 541
Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development
Szente, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00092-1 · Cited by 540
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
Martin'S Physical Pharmacy And Pharmaceutical Sciences
Sinko (2008) · Cited by 520
Attwood, D., & Florence, A. T. (1983) · Springer eBooks · doi:10.1007/978-94-009-5775-6 · Cited by 520
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo
Brunham, L. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27352 · Cited by 519
Micro- and nanoparticle production by electrospraying
Jaworek, A. (2007) · Powder Technology · doi:10.1016/j.powtec.2007.01.035 · Cited by 512
Evaluation of amorphous solid dispersion properties using thermal analysis techniques
Baird, J. A., & Taylor, L. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.009 · Cited by 512
Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.013 · Cited by 510
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
Marsac, P. J., Li, T., & Taylor, L. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9721-1 · Cited by 507
Trends in Solubility of Polymorphs
Pudipeddi, M., & Serajuddin, A. T. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20302 · Cited by 505
Applied Surfactants: Principles and Applications
Tadros, T. F. (2005) · Wiley eBooks · doi:10.1002/3527604812 · Cited by 503
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Bridging solubility between drug discovery and development
Di, L., Fish, P. V., & Mano, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.007 · Cited by 491
Hernell, O., Staggers, J. E., & Carey, M. C. (1990) · Biochemistry · doi:10.1021/bi00460a012 · Cited by 490
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Berge, S. M., Bighley, L. D., & Monkhouse, D. C. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660104 · Cited by 479
Yoshioka, M., Hancock, B. C., & Zografi, G. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600831211 · Cited by 470
Kennedy, D., & Norman, C. (2005) · Science · doi:10.1126/science.309.5731.75 · Cited by 467
Zhang, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.009 · Cited by 462
General principles of pharmaceutical solid polymorphism A supramolecular perspective
Rodriguez‐Spong, B., Price, C. P., Jayasankar, A., Matzger, A. J., & Rodríguez‐Hornedo, N. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.005 · Cited by 455
Dahan, A., Miller, J. M., & Amidon, G. L. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9144-x · Cited by 453
Production methods for nanodrug particles using the bottom-up approach
Chan, H.-K., & Kwok, P. C. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.011 · Cited by 451
Qian, F., Huang, J., & Hussain, M. A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22074 · Cited by 448
Micellar solubilization of drugs.
Rangel‐Yagui, C. D. O., Pessoa, A., & Tavares, L. C. (2005) · PubMed · Cited by 447
Pharmaceutical Processing with Supercritical Carbon Dioxide
Subramaniam, B., Rajewski, R. A., & Snavely, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9700661 · Cited by 444
Hofmann, A. F., & Borgström, B. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104909 · Cited by 443
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Self-citationRole of Thermodynamic, Molecular, and Kinetic Factors in Crystallization from the Amorphous State
Bhugra, C., & Pikal, M. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21138 · Cited by 442
Sethia, S., & Squillante, E. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.025 · Cited by 442
Mechanisms of drug release from cyclodextrin complexes
Stella, V. J., Rao, V. M., Zannou, E. A., & Zia, V. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00052-0 · Cited by 442
Impact of solid state properties on developability assessment of drug candidates
Huang, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.007 · Cited by 438
Lipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 433
Gut instincts: Explorations in intestinal physiology and drug delivery
McConnell, E. L., Fadda, H. M., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.012 · Cited by 431
Wei, Z., Hao, J., Yuan, S., Li, Y., Juan, W., Sha, X., & Fang, X. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.030 · Cited by 427
Butler, J. M., & Dressman, J. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22217 · Cited by 427
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426
Block copolymer nanostructures
Smart, T., Lomas, H., Massignani, M., Flores-Merino, M. V., Perez, L. R., & Battaglia, G. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70043-4 · Cited by 422
CyclodextrinsEnabling Excipients: Their Present and Future Use in Pharmaceuticals
Thompson, D. O. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i1.10 · Cited by 421
Gao, L., Zhang, D., & Chen, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9357-4 · Cited by 420
Leucht, C., Heres, S., Kane, J. M., Kissling, W., Davis, J. M., & Leucht, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.020 · Cited by 419
An Electron Microscopic Study of the Intestinal Villus
Palay, S. L., & Karlin, L. J. (1959) · The Journal of Cell Biology · doi:10.1083/jcb.5.3.373 · Cited by 413
High throughput solubility measurement in drug discovery and development
Alsenz, J., & Kansy, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.007 · Cited by 412
Assessing the performance of amorphous solid dispersions
Newman, A., Knipp, G., & Zografi, G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23031 · Cited by 406
Krieger, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14011 · Cited by 406
Peltonen, L., & Hirvonen, J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01022.x · Cited by 405
Spray Drying Technique. I: Hardware and Process Parameters
Cal, K., & Sollohub, K. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21886 · Cited by 402
Surfactant systems: their use in drug delivery
Lawrence, M. J. (1994) · Chemical Society Reviews · doi:10.1039/cs9942300417 · Cited by 401
Forster, A., Hempenstall, J., Tucker, I., & Rades, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00801-8 · Cited by 400
In vitro hemolysis: Guidance for the pharmaceutical scientist
Amin, K., & Dannenfelser, R.-M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20627 · Cited by 397
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
Cardiac disturbances during the administration of taxol.
Rowinsky, E. K., McGuire, W. P., Guarnieri, T., Fisherman, J. S., Christian, M. C., & Donehower, R. C. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1704 · Cited by 395
Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms
Tang, B., Cheng, G., Gu, J.-C., & Xu, C.-H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.04.006 · Cited by 393
Controlling drug nanoparticle formation by rapid precipitation
D'Addio, S. M., & Prud'homme, R. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.04.005 · Cited by 392
Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability
Smith, A. J., Kavuru, P., Wojtas, L., Zaworotko, M. J., & Shytle, R. D. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200209j · Cited by 390
In vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389
Self-citationApproaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 388
Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
Hu, J., Johnston, K. P., & Williams, R. O. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120030422 · Cited by 387
Mosharraf, M., & Nyström, C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00033-f · Cited by 386
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Metadata
- Authors
- Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 315-499
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2133061394
- Cited by
- 1,570
- References
- 865
- FWCI
- 56.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.